创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

徐杰, 王敏, 宋瑞, 葛卫红, 张尊建. 药源性糖尿病发病机制的研究进展[J]. 药学进展, 2021, 45(9): 707-714.
引用本文: 徐杰, 王敏, 宋瑞, 葛卫红, 张尊建. 药源性糖尿病发病机制的研究进展[J]. 药学进展, 2021, 45(9): 707-714.
XU Jie, WANG Min, SONG Rui, GE Weihong, ZHANG Zunjian. Progress of Research on Pathogenesis of Drug-Induced Diabetes Mellitus[J]. Progress in Pharmaceutical Sciences, 2021, 45(9): 707-714.
Citation: XU Jie, WANG Min, SONG Rui, GE Weihong, ZHANG Zunjian. Progress of Research on Pathogenesis of Drug-Induced Diabetes Mellitus[J]. Progress in Pharmaceutical Sciences, 2021, 45(9): 707-714.

药源性糖尿病发病机制的研究进展

Progress of Research on Pathogenesis of Drug-Induced Diabetes Mellitus

  • 摘要: 药源性糖尿病(DIDM)是由药物引起的一种继发性糖尿病,影响因素众多且发病机制复杂。临床资料显示,包括钙调神经磷酸酶抑制剂、糖皮质激素、抗高血压药物、调脂及抗动脉粥样硬化和抗精神病药物等在内的多种常用药均可引发DIDM。对引发DIDM的药物类别及近年来DIDM发病机制的研究情况进行综述,旨在为DIDM的预防与进一步治疗提供参考。

     

    Abstract: Drug-induced diabetes mellitus (DIDM) is secondary diabetes caused by drugs, with different influencing factors and complex pathogenesis. Clinical data have shown that a variety of commonly used drugs, including calcineurin inhibitors, glucocorticoids, antihypertensives, lipid-lowering and anti-atherosclerotic drugs, and antipsychotic drugs, can cause DIDM. This article reviews the research on pathogenesis of DIDM in the past years according to the drug category, in an attempt to provide guidance for the prevention and treatment of DIDM.

     

/

返回文章
返回